Skip to main content

Tenaris Announces 2025 Fourth Quarter and Annual Results

The financial and operational information contained in this press release is based on audited consolidated financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Free Cash Flow, Net cash / debt and Operating working capital days. See exhibit I for more details on these alternative performance measures. LUXEMBOURG, Feb. 18, 2026 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) today announced its results for the fourth quarter and year ended December 31, 2025 in comparison with its results for the fourth quarter and year ended December...

Continue reading

Firan Technology Group Corporation (“FTG”) Announces Full Year and Fourth Quarter 2025 Financial Results

TORONTO, Feb. 18, 2026 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX: FTG) (OTCQX: FTGFF) today announced financial results for the full year and the fourth quarter 2025. Full Year Financial Highlights:Bookings: $209.9 million for 2025, marking a 14% increase over 2024. Backlog: $148.5 million at the end of 2025, a 21% rise from the previous year end inclusive of FLYHT acquisition. Revenue: $191.0 million, an 18% increase over 2024. Adjusted EBITDA: $32.7 million in 2025, up 27% from $25.8 million in 2024. Adjusted Net Earnings: $13.5 million in 2025, an increase of 31% from 2024. Operating Cash Flow Less Lease Payments: Generated operating cash flow less lease payments of $13.7 million in 2025. Net Debt: Maintained a strong balance sheet with net debt of $8.3 million, or 0.3X trailing 12 months EBITDA, including...

Continue reading

OR Royalties Reports Record 2025 Results and Provides 2026 GEO Delivery Guidance and New 5-Year Outlook

Record annual revenues of $277.4 million and record operating cash flows of $245.6 million MONTRÉAL, Feb. 18, 2026 (GLOBE NEWSWIRE) — OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to announce its consolidated financial results for the year-end 2025. Amounts presented are in United States dollars, except where otherwise noted. 2025 Financial Highlights80,775 gold equivalent ounces (“GEOs1”) earned (80,740 GEOs in 2024); Record revenues from royalties and streams of $277.4 million ($191.2 million in 2024); Record cash flows generated by operating activities of $245.6 million ($159.9 million in 2024); Record cash margin2 of $268.3 million or 96.7% ($184.4 million or 96.5% in 2024); Record net earnings of $206.1 million, $1.10 per basic share ($16.3 million, $0.09 per basic share in 2024); Record...

Continue reading

Eramet: structural measures to strengthen balance sheet and prepare the future, after a challenging year 2025

Paris, 18 February 2026, 6:45 p.m. PRESS RELEASE Eramet: structural measures to strengthen balance sheet and prepare the future, after a challenging year 2025Safety – a top priority for the Group: focused initiatives undertaken at the PT Weda Bay Nickel JV site (Indonesia) Decisive operational milestones:Successful ramp-up of lithium production at Centenario in Argentina, with a capacity of close to 75% of design achieved in December Eramet Grande Côte, Eramet’s first mining site to achieve IRMA 50 performance levelDeteriorated financial performance in a challenging environment:Adjusted EBITDA1 at €372m, down 54% vs. 2024:An unfavourable price and exchange rate impact (-€285m at Group level) which weighed heavily on manganese Permit restrictions, combined with the start-up of new mining production sites, which impacted...

Continue reading

VINCI Autoroutes and VINCI Airports traffic in January 2026

Nanterre, 18 February 2026 VINCI Autoroutes and VINCI Airports traffic in January 2026 I-      Change in VINCI Autoroutes’ intercity networks traffic  January  % change 2026/2025VINCI Autoroutes -1.9%Light vehicles -2.2%Heavy vehicles -0.9%Traffic at VINCI Autoroutes in January was disrupted at the start of the year by snowfall and farmers’ blockades. Heavy vehicle traffic was also affected by one fewer working day than in January 2025. Excluding these effects, traffic would have been stable, bearing in mind that January is traditionally not representative of the annual trend. II-      Change in VINCI Airports passenger traffic1  January  % change 2026/2025VINCI Airports +1.0%Portugal (ANA) +4.1%United Kingdom* -0.9%France -1.9%Serbia +6.5%Hungary +2.9%Mexico (OMA) +6.5%United States of...

Continue reading

Euronext publishes Q4 and full year 2025 results

Euronext publishes Q4 and full year 2025 results In 2025, Euronext delivered another year of double-digit growth, driven by the expansion of non-volume-related businesses, resilient trading, clearing revenues and cost discipline. Euronext will accelerate the execution of its strategic plan in 2026. Amsterdam, Athens, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 18 February 2026 – Euronext, the leading European capital market infrastructure, today publishes its results for the fourth quarter and full year 2025.Full year 2025 underlying revenue and income1 was up +12.1%2 to €1,823.2 million:Non-volume-related revenue and income represented 59% of total revenue and income and covered 157% of underlying operating expenses, excluding D&A3:Securities Services revenue grew to €330.7 million (+6.9%), driven by double-digit revenue...

Continue reading

EuroDry Ltd. Sets Date for the Release of Fourth Quarter 2025 Results, Conference Call and Webcast

ATHENS, Greece, Feb. 18, 2026 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that it will release its financial results for the fourth quarter ended December 31, 2025, on Thursday, February 19, 2026 after market closes in New York. On the next day, Friday, February 20, 2026, at 8:00 a.m. Eastern Time, the Company’s management will host a conference call and webcast to discuss the results. Conference Call details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International Dial In). Please quote “EuroDry” to the operator and/or conference ID 13758897....

Continue reading

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 million IM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR Milestone Strategic Transformation Completed with Divestitures and Focus on IM8 Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero Debt Company to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at https://ir.prenetics.comNEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced financial results for fourth quarter and full year ended December 31,...

Continue reading

Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results

MELBOURNE, Australia, Feb. 18, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and metastatic cancer, today announced an update on corporate progress and reported half yearly financial results as of December 31, 2025 (Year end June 30). Corporate and R&D Highlights Accelerates IP Momentum: Files Four Provisional Patent Applications – Strengthening Global Protection for Breakthrough Proenzyme Formulations Four provisional patent applications were filed with IP Australia detailing two new methods to treat resistant cancer and fibrosis, methods of producing synthetic trypsinogen and chymotrypsinogen, and innovative formulations of trypsinogen and chymotrypsinogen. As these applications advance to national phase entry...

Continue reading

Aware Sets Fourth Quarter and Full Year 2025 Webcast for Wednesday, March 4, 2026, at 5:00 p.m. Eastern Time

BURLINGTON, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), global leader in biometric identity and authentication solutions, will hold a webcast on Wednesday, March 4, 2026, at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2025. Financial results will be issued in a press release before the call. Aware management will host the webcast presentation, followed by a question-and-answer session. Date: Wednesday, March 4, 2026Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)Webcast: Register Here Interested parties may submit questions in advance of the webcast by emailing AWRE@gateway-grp.com. The presentation will be made available for replay in the investor relations section of the Company’s website. The audio recording will be available for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.